With approximately 42% of American adults suffering from the chronic condition, the approval of the injectable gives patients a once-weekly, non-surgical option to lose weight.

The vision will enable seniors to live their best lives by providing access to high quality, innovative and valued care and technology.

Like many hospitals, CarePoint Health’s three Hudson County facilities have had to face challenges this past year, the system's CEO Dr. Achintya Moulick writes, "but emerged stronger than ever. ... Hoboken University Medical Center, Bayonne Medical Center and Christ Hospital, have saved thousands of lives ... and as we reach the critical vaccination levels in this country and we begin to surface from the pandemic, I felt the need to tell our story. "

Sixty-one percent of residents said they would support some type of credential that would establish evidence that someone was inoculated against COVID-19.

"By creating a reliable and affordable source of nutritious food, we're working to reduce both food insecurity and diet-related chronic illnesses such as diabetes, high blood pressure, and obesity," said Assistant Vice President of Community Health Engagement April, a registered dietitian who helped bring the initiative to fruition.

The deal broadens the company’s oncology platform of targeted alpha therapies (TATs), as it picks up exclusive rights to two investigational therapies for prostate cancer.

The Jersey City health care system now participates with all major insurance carriers, providing the majority of patients in Hudson County in-network access.

The Matawan-based buyer said the addition of software provider Behaviorsoft will enhance its product offering for small applied behavior analysis therapy practices.

Among those who said they would not get the shot, 67% said they were seriously concerned about the side effects, while 58% cited government mistrust, 57% said they were rolled out too quickly, and 55% did not believe they needed it.

The 18 graduates begin careers after completing an accelerated three-year medical degree.

The company, with a majority-female leadership team, will be headquartered in Jersey City with a singular vision: To make a better and healthier every day for every woman.

Scynexis Inc. in Jersey City is partnering with Amplity Health, a global contract commercialization organization, to support U.S. commercialization of the treatment, with a commercial launch scheduled in the second half of 2021.